Telehealth for Opioid Use Disorder Treatment
This study is developing and testing a new telehealth program to help people with opioid use disorder (OUD) get and stay in treatment. The program will use buprenorphine, a medication that helps with OUD. Researchers want to understand how to best use telehealth to make OUD treatment fair and effective, especially for people who might have trouble accessing care. They will enroll 60 participants, including those already receiving buprenorphine treatment and those new to treatment. The main goal is to see how well people stay engaged with their treatment at 14, 30, and 90 days.
- Study design
- This is an interventional study planning to enroll 60 participants. It is a pilot trial to develop and test a telehealth intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for treatment engagement at 14, 30, and 90 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Treatment Engagement14,30, 90 days
Enrolled in care; attended scheduled follow up visits or has rescheduled missed visits with care team; has filled, active buprenorphine prescription (from self-report and EHR)